Non steroidal anti-inflammatory drug-based pain control for minimally invasive direct coronary artery bypass surgery.
Publication/Presentation Date
1-1-1999
Abstract
Minimally invasive direct coronary artery bypass (MIDCAB) surgery has become an attractive alternative technique to treat coronary artery insufficiency. Changes in surgical and anesthesia techniques have led to reduced pulmonary morbidity associated with the operation. Early extubation is typically expected. However, postoperative pain management becomes even more important with early extubation. We describe our technique of a NSAID-based protocol with indomethicin and Torodal that has been safe and effective in over 175 patients following MIDCAB.
Volume
2
Issue
2
First Page
169
Last Page
171
ISSN
1098-3511
Published In/Presented At
Lin, J. C., Szwerc, M. F., & Magovern, J. A. (1999). Non steroidal anti-inflammatory drug-based pain control for minimally invasive direct coronary artery bypass surgery. The heart surgery forum, 2(2), 169–171.
Disciplines
Medicine and Health Sciences
PubMedID
11276474
Department(s)
Department of Surgery
Document Type
Article